Publications

Dr. Ying Liu’s most recent publications.

  1. RNA m(6)A modification orchestrates a LINE-1-host interaction that facilitates retrotransposition and contributes to long gene vulnerability. Xiong F, Wang R, Lee JH, Li S, Chen SF, Liao Z, Hasani LA, Nguyen PT, Zhu X, Krakowiak J, Lee DF, Han L, Tsai KL, Liu Y, Li W. Cell Research 2021 Aug;31(8):861-885. doi: 10.1038/s41422-021-00515-8. Epub 2021 Jun 9.PMID: 34108665
  2. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts. Li D, Li S, Xue AZ, Smith Callahan LA, Liu Y. Medicine (Baltimore) 2020 Mar;99(12):e18815. doi: 10.1097/MD.0000000000018815.PMID: 32195924
  3. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome. Xu R, Brawner AT, Li S, Liu JJ, Kim H, Xue H, Pang ZP, Kim WY, Hart RP, Liu Y, Jiang P. Cell Stem Cell 2019 Jun 6;24(6):908-926.e8. doi: 10.1016/j.stem.2019.04.014. Epub 2019 May 23.PMID: 31130512
  4. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment. Jia D, Li S, Li D, Xue H, Yang D, Liu Y. Aging (Albany NY) 2018 Apr 16;10(4):592-605. doi: 10.18632/aging.101415.PMID: 29676997
  5. Effects of Propofol Treatment in Neural Progenitors Derived from Human-Induced Pluripotent Stem Cells. Long B, Li S, Xue H, Sun L, Kim DH, Liu Y. Neural Plasticity 2017;2017:9182748. doi: 10.1155/2017/9182748. Epub 2017 Oct 8.PMID: 29119024
  6. One-Step piggyBac Transposon-Based CRISPR/Cas9 Activation of Multiple Genes. Li S, Zhang A, Xue H, Li D, Liu Y. Molecular Therapy Nucleic Acids 2017 Sep 15;8:64-76. doi: 10.1016/j.omtn.2017.06.007. Epub 2017 Jun 15.PMID: 28918057
  7. Human neural progenitors derived from integration-free iPSCs for SCI therapy. Liu Y, Zheng Y, Li S, Xue H, Schmitt K, Hergenroeder GW, Wu J, Zhang Y, Kim DH, Cao Q. Stem Cell Research 2017 Mar;19:55-64. doi: 10.1016/j.scr.2017.01.004. Epub 2017 Jan 5.PMID: 28073086
  8. Metformin treatment reduces temozolomide resistance of glioblastoma cells. Yang SH, Li S, Lu G, Xue H, Kim DH, Zhu JJ, Liu Y. Oncotarget 2016 Nov 29;7(48):78787-78803. doi: 10.18632/oncotarget.12859.PMID: 27791206
  9. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Liu Y, Deng W. Brain Research 2016 May 1;1638(Pt A):30-41. doi: 10.1016/j.brainres.2015.09.023. Epub 2015 Sep 28.PMID: 26423934
  10. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System. Li S, Xue H, Wu J, Rao MS, Kim DH, Deng W, Liu Y. Stem Cells and Development 2015 Dec 15;24(24):2925-42. doi: 10.1089/scd.2015.0131. Epub 2015 Nov 5.PMID: 26414932
  11. Genetic Modification in Human Pluripotent Stem Cells by Homologous Recombination and CRISPR/Cas9 System. Xue H, Wu J, Li S, Rao MS, Liu Y. Methods in Molecular Biology 2016;1307:173-90. doi: 10.1007/7651_2014_73.PMID: 24615461
  12. Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system. Li S, Xue H, Long B, Sun L, Truong T, Liu Y. Journal of Visualized Experiments 2015 May 28;(99):e52539. doi: 10.3791/52539.PMID: 26065872
  13. Role of astroglia in Down’s syndrome revealed by patient-derived human-induced pluripotent stem cells. Chen C, Jiang P, Xue H, Peterson SE, Tran HT, McCann AE, Parast MM, Li S, Pleasure DE, Laurent LC, Loring JF, Liu Y, Deng W. Nature Communications 2014 Jul 18;5:4430. doi: 10.1038/ncomms5430.PMID: 25034944
  14. Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Macarthur CC, Xue H, Van Hoof D, Lieu PT, Dudas M, Fontes A, Swistowski A, Touboul T, Seerke R, Laurent LC, Loring JF, German MS, Zeng X, Rao MS, Lakshmipathy U, Chesnut JD, Liu Y. Stem Cells and Development 2012 Jan 20;21(2):191-205. doi: 10.1089/scd.2011.0163. Epub 2011 Aug 4.PMID: 21699412
  15. OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Liu Y, Jiang P, Deng W. Nature Protocols 2011 May;6(5):640-55. doi: 10.1038/nprot.2011.310. Epub 2011 Apr 21.PMID: 21527921
  16. Generation of platform human embryonic stem cell lines that allow efficient targeting at a predetermined genomic location. Liu Y, Thyagarajan B, Lakshmipathy U, Xue H, Lieu P, Fontes A, MacArthur CC, Scheyhing K, Rao MS, Chesnut JD. Stem Cells and Development 2009 Dec;18(10):1459-72. doi: 10.1089/scd.2009.0047.PMID: 19355838
  17. A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Xue H, Wu S, Papadeas ST, Spusta S, Swistowska AM, MacArthur CC, Mattson MP, Maragakis NJ, Capecchi MR, Rao MS, Zeng X, Liu Y. STEM CELLS 2009 Aug;27(8):1836-46. doi: 10.1002/stem.129.PMID: 19544414
  18. Expression profiling of human glial precursors. Campanelli JT, Sandrock RW, Wheatley W, Xue H, Zheng J, Liang F, Chesnut JD, Zhan M, Rao MS, Liu Y. BMC Developmental Biology 2008 Oct 23;8:102. doi: 10.1186/1471-213X-8-102.PMID: 18947415
  19. Genome wide profiling of human embryonic stem cells (hESCs), their derivatives and embryonal carcinoma cells to develop base profiles of U.S. Federal government approved hESC lines. Liu Y, Shin S, Zeng X, Zhan M, Gonzalez R, Mueller FJ, Schwartz CM, Xue H, Li H, Baker SC, Chudin E, Barker DL, McDaniel TK, Oeser S, Loring JF, Mattson MP, Rao MS. BMC Developmental Biology 2006 May 3;6:20. doi: 10.1186/1471-213X-6-20.PMID: 16672070
  20. Olig genes are expressed in a heterogeneous population of precursor cells in the developing spinal cord. Liu Y, Rao MS. GLIA 2004 Jan 1;45(1):67-74. doi: 10.1002/glia.10303.PMID: 14648547